Bharath Kumar Tirupakuzhi Vijayaraghavan

Employment

• Nat Intensive Care Surveillance-MORU Senior Researcher
  2026 - 2026
• University of Edinburgh Clinical Research Fellow
  2024 - 2026
• Apollo Hospitals Chennai Consultant
  2018 - Present
• Sunnybrook Health Sciences Centre Clinical Fellow
  2015 - 2018

Education

• University of Amsterdam Ph.D.
  2021 - 2025
• London School of Hygiene & Tropical Medicine MSc.
  2017 - 2021
• European Society of Intensive Care Medicine EDIC
  2015 - Present
• National University Hospital Fellowship
  2013 - 2014
• Post Graduate Institute of Medical Education and Research MD
  2009 - 2011
• MS Ramaiah Medical College MBBS
  2002 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (98)

• Understanding heterogeneity of treatment effect in critical care trials
  Critical Care Science 2026 DOI: 10.62675/2965-2774.20260021
  +Save
• Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE)
  The Lancet Infectious Diseases 2026 DOI: 10.1016/s1473-3099(25)00500-6
  +Save
• Patient, family and clinician priorities for critical care research in Asia and Africa: a James Lind Alliance Priority Setting Partnership using modified Delphi and nominal group techniques.
  BMJ global health 2026 DOI: 10.1136/bmjgh-2025-019904
  +Save
• Dengue therapeutics consortium 2025: a global collaboration in action.
  BMJ public health 2026 DOI: 10.1136/bmjph-2025-004043
  +Save
• Association Between Sex and Clinical Outcomes for Critically Ill Patients in India: A Registry-Embedded Cohort Study
  Critical Care Medicine 2026 DOI: 10.1097/CCM.0000000000007163
  +Save
• The case for an international severity of illness scoring system
  Critical Care Science 2025 DOI: 10.62675/2965-2774.20250293
  +Save
• A Core Outcome Set for Adult General ICU Patients.
  Critical care medicine 2025 DOI: 10.1097/ccm.0000000000006556
  +Save
• Persistent Critical Illness Among Intensive Care Patients in India: A Registry-Embedded Cohort Study
  Critical Care Medicine 2025 DOI: 10.1097/CCM.0000000000006743
  +Save
• Epinephrine vs Norepinephrine as the Initial Vasoactive Agent in Pediatric Septic Shock: A Feasibility Randomized Controlled Trial for Recruitment Rates and Protocol Adherence, the Epinephrine vs Norepinephrine in Pediatric Septic Shock Trial.
  Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 2025 DOI: 10.5005/jp-journals-10071-25043
  +Save
• The authors reply:
  Critical Care Medicine 2025 DOI: 10.1097/CCM.0000000000006864
  +Save